Extreme risk category in the stratification system cardiovascular complications

Authors

  • I. V. Sergienko FSU Russian Cardiological Research and Production Complex of the Ministry of Health of the Russian Federation
  • M. V. Shestakova FSBI "National Medical Center for Preventive Medicine"
  • S. A. Boystov FSBI "National Medical Center for Preventive Medicine"
  • A. S. Ametov FSBI "National Medical Center for Preventive Medicine"
  • M. B. Antsiferov FSBI "National Medical Center for Preventive Medicine"
  • V. V. Kukharchuk FSBI "National Medical Center for Preventive Medicine"
  • D. A. Zateishchikov FSBI "National Medical Center for Preventive Medicine"
  • M. V. Ezhov FSBI "National Medical Center for Preventive Medicine"
  • V. S. Gurevich FSBI "National Medical Center for Preventive Medicine"
  • A. S. Galyavich ФГБУ «Национальный медицинский центр профилактической медицины»
  • M. I. Voevoda FSBI "National Medical Center for Preventive Medicine"
  • D. V. Duplyakov FSBI "National Medical Center for Preventive Medicine"
  • O. L. Barbarash FSBI "National Medical Center for Preventive Medicine"
  • Yu. Sh. Khalimov FSBI "National Medical Center for Preventive Medicine"
  • G. P. Arutyunov FSBI "National Medical Center for Preventive Medicine"
  • Yu. A. Karpov FSBI "National Medical Center for Preventive Medicine"
  • M. G. Bubnova FSBI "National Medical Center for Preventive Medicine"
  • L. Yu. Drozdova FSBI "National Medical Center for Preventive Medicine"
  • A. A. Ansheles FSBI "National Medical Center for Preventive Medicine"
  • I. V. Samorodskaya FSBI "National Medical Center for Preventive Medicine"
  • N. A. Koziolova FSBI "National Medical Center for Preventive Medicine"
  • O. M. Drapkina FSBI "National Medical Center for Preventive Medicine"

Keywords:

extreme risk, cardiovascular risk stratification, type 2 diabetes, progression of atherosclerosis

Abstract

The conclusion of the advisory board demonstrates the necessity of introducing a new risk category for cardiovascular complications: the extreme risk category. The article presents the analysis of the studies that were the basis for the introduction of this risk category. The following patients groups may be classified as an extreme risk category: combination of clinically significant atherosclerotic cardiovascular disease with diabetes mellitus type 2; atherosclerotic cardiovascular disease with cardiovascular complications occurred despite adequate lipid lowering therapy and/or achieved LDL cholesterol level ≤1.5 mmol/l. Management of extreme risk patients is discussed, that includes not only requirements of achievement of
LDL cholesterol, blood pressure and HbA1c target levels, but also using of drugs with proved effectiveness in reducing cardiovascular risk.

Downloads

Download data is not yet available.

Published

2018-12-23

How to Cite

Sergienko I. V., Shestakova M. V., Boystov S. A., Ametov A. S., Antsiferov M. B., Kukharchuk V. V., Zateishchikov D. A., Ezhov M. V., Gurevich V. S., Galyavich A. S., Voevoda M. I., Duplyakov D. V., Barbarash O. L., Khalimov Y. S., Arutyunov G. P., Karpov Y. A., Bubnova M. G., Drozdova L. Y., Ansheles A. A., Samorodskaya I. V., Koziolova N. A., Drapkina O. M. Extreme risk category in the stratification system cardiovascular complications // The Journal of Atherosclerosis and Dyslipidemias. 2018. VOL. № 4 (33). PP. 8–16.

Issue

Section

Key Article